Drilldown: Medicines
Appearance
Medicines > classes
:
Antidepressant
or
[[:Category:Antithyroid_agents|Antithyroid agent]]
& routes:
Oral 
:
Antidepressant
or
[[:Category:Antithyroid_agents|Antithyroid agent]]
& routes:
Oral 
Use the filters below to narrow your results.
Serotonin–norepinephrine reuptake inhibition (balanced) (1) ·
TrkB/BDNF'"`UNIQ--ref-00000084-QINU`"' '"`UNIQ--vote-00000085-QINU`"' (1) ·
'"`UNIQ--vote-00000ECD-QINU`"' Agranulocytosis is the most-feared adverse effect (~0.3%, usually first 90 days of treatment; warn patients to seek urgent CBC for fever or severe sore throat). Hepatotoxicity is class-recognized but more often associated with PTU'"`UNIQ--ref-00000ECE-QINU`"'. (1)
Showing below up to 3 results in range #1 to #3.

